新葡的京首頁-欢迎您

ABOUT USABOUT US

H-DataNet（Beijing）Technology Co.,Ltd.（H-DataNet）was founded in November 2022,with three holding subsidiaries[Genelife（Beijing）Technology Co.Ltd.（Genelife），ZHIBAO（Beijing0Technology Co.,Ltd.（ZHIBAO），Remedial AI（Beijing）Technology Co.,Ltd（Remedial AI）]，H-DataNet focuses on the application of medical and healthcare big data and artificial intelligence technology to provide accurate and intelligent solutions for hospitals, the Health Commission, the Health Insurance Bureau and the Center for Disease Control and Prevention, realizing the linkage of healthcare, pharmaceuticals and healthcare insurance, so as to significantly improve the efficiency of the healthcare industry chain,and promote the sustainable and healthy development of the medical and healthcare industry.

There are3branches
Holding subsidiaries
Serving30⁺
Fudan top 100+ hospitals
Get100⁺items
Intellectual property
Have500⁺billions
Data governance experience

Product and solutionsProduct and solutions

Data middle platform
Healthcare data Intelligent operating system; Intelligent research
Dramatically improve the efficiency and quality of clinical research

Specialized disease/ Indicator pools Research project management Research search Research variables analysis Data export; Intelligent medicare
Significantly improve the effect of medicare fee control and evaluation ability

Medicare Payment Data Analytics Medicare Oversight Group/SaaS/Single Hospital; Intelligent clinical
Reducing the burden and increasing the efficiency of clinical diagnosis and treatment and medical management

Patient panorama view Similar population exploration Clinical quality monitoring Critical care data application Chinese clinical terminology knowledge; Intelligent disease control
Enhance the ability of infectious disease outbreak monitoring, early warning and prediction

Normalcy monitoring Perception early warning Intelligent epidemiological survey Prevention and control trend prediction Prevention and control of auxiliary decision-making Intelligent risk assessment; Intelligent operation and management
Unleash the value of data, drive the integration of business and finance, and the integration of medical management

Operations management analytics Operational decision support Medical treatment management Refinement management Data reporting requirements; Intelligent medicine
Integrate data related to drug development, Explore the potential value of drugs

Drug repurposing Target discovery Virtual screening Molecule generation

Customer casesCustomer cases

The First Affiliated Hospital of Xi'an Jiaotong University

Guangdong Provincial People's Hospital

The First Hospital of Jilin University

Wuhan University Central South Hospital

West China Second Hospital of Sichuan University

Sichuan Provincial People's Hospital

Jiangsu Provincial Tumor Hospital

Peking University People's Hospital

NEWSNews